MedTrace Logo

mHealth Intervention to Support Diabetes Medication Adherence

NCT05006872 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 742

Last updated 2025-02-28

Study results available
· View outcomes & findings →

Summary

This study aims at evaluating the effectiveness of an intervention based on the use of a mobile-device based system delivering automated, tailored brief text messages to offer support for medicine use and lifestyle recommendations alongside usual care to people with type 2 diabetes.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DEVICE

DIABE-TEXT

Participants will receive 170 text messages in their mobile phones during twelve months.

Sponsors & Collaborators

  • Fundació d'investigació Sanitària de les Illes Balears

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-06
Primary Completion
2023-03-31
Completion
2023-04-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05006872 on ClinicalTrials.gov